People with Parkinson's design Clinical Trials Charter to improve communication about, recruitment to, and retention in Parkinson's clinical trials

被引：0
|
作者：
Mathur, S. [1 ,2 ]
DeWitte, S. [2 ,3 ]
Robledo, I. [2 ,3 ]
Isaacs, T. [2 ,4 ]
Stamford, J. [2 ,4 ]
机构：
[1] Designing Cure Inc, Toronto, CA USA
[2] Parkinsons Movement, London, England
[3] Parkinsons Act Network, Washington, DC USA
[4] Cure Parkinsons Trust, London, England
来源：
MOVEMENT DISORDERS | 2015年 / 30卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
8
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [41] Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?
    Hung, Albert Y.
    Schwarzschild, Michael A.
    CURRENT OPINION IN NEUROLOGY, 2007, 20 (04) : 477 - 483
  • [42] Clinical trials: motivations and concerns of Parkinson's disease (PD) patients
    Valadas, A.
    Guedes, L.
    Mestre, T.
    Coelho, M.
    Rosa, M.
    Noronha, A.
    Finisterra, M.
    Ferreira, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 558 - 558
  • [43] Cell transplantation in Parkinson's disease: Implications for human clinical trials
    Grossman, RG
    NEUROSURGERY, 2001, 49 (03) : 580 - 582
  • [44] Nutritional and dietary clinical trials for Parkinson's disease: a narrative review
    Giannakis, Alexandros
    Chondrogiorgi, Maria
    Konitsiotis, Spiridon
    Sidiropoulos, Christos
    JOURNAL OF NEURAL TRANSMISSION, 2025, 132 (04) : 519 - 536
  • [45] GDNF treatment in Parkinson's disease: time for controlled clinical trials?
    Brundin, P
    BRAIN, 2002, 125 : 2149 - 2151
  • [46] Interpreting the Results of Parkinson's Disease Clinical Trials: Time for a Change
    Holford, Nick H. G.
    Nutt, John G.
    MOVEMENT DISORDERS, 2011, 26 (04) : 569 - 577
  • [47] A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson's Disease
    Chou, Kelvin L.
    Amick, Melissa M.
    Brandt, Jason
    Camicioli, Richard
    Frei, Karen
    Gitelman, Darren
    Goldman, Jennifer
    Growdon, John
    Hurtig, Howard I.
    Levin, Bonnie
    Litvan, Irene
    Marsh, Laura
    Simuni, Tanya
    Troester, Alexander I.
    Uc, Ergun Y.
    MOVEMENT DISORDERS, 2010, 25 (15) : 2501 - 2507
  • [48] Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment
    Diguet, E
    Gross, CE
    Bezard, E
    Tison, F
    Stefanova, N
    Wenning, GK
    NEUROLOGY, 2004, 62 (01) : 158 - 158
  • [49] Motivations and concerns of Parkinson's disease patients to participate in clinical trials
    Valadas, A.
    Coelho, M.
    Finisterra, M.
    Noronha, A.
    Rosa, M.
    Sampaio, C.
    Ferreira, J.
    MOVEMENT DISORDERS, 2009, 24 : S284 - S284
  • [50] Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia
    D. Aarsland
    C. Ballard
    A. Rongve
    M. Broadstock
    P. Svenningsson
    Current Neurology and Neuroscience Reports, 2012, 12 : 492 - 501
12345